| Dr Florencio Jorge Gonzalez, MD | |
|
3100 Clay Ave, Suite # 299, Orlando, FL 32804-4026 | |
| (407) 447-1628 | |
| Not Available |
| Full Name | Dr Florencio Jorge Gonzalez |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 3100 Clay Ave, Orlando, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164649786 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | ME79378 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Florencio Jorge Gonzalez, MD 3100 Clay Ave Ste 299, Orlando, FL 32804-4020 Ph: (407) 447-1628 | Dr Florencio Jorge Gonzalez, MD 3100 Clay Ave, Suite # 299, Orlando, FL 32804-4026 Ph: (407) 447-1628 |
News Archive
Weill Cornell Medical College in Qatar hosted a detailed talk about a virus that's causing concern around the world. The recent cause of an interruption in local school openings, H1N1 information was presented in timely fashion by Dr. Abdullatif Al-Khal, head of the communicable disease unit at Hamad Medical Corporation, and Dr. Ravinder Mamtani, Professor of Public Health at WCMC-Q.
Long-term risks of invasive cancer and recurrence of severe cervical intraepithelial neoplasia (CIN) are higher among women previously treated for CIN, compared with those with no CIN diagnosis, according to data from a large, retrospective cohort study published in the May 12 online issue of the Journal of the National Cancer Institute
SynCo Bio Partners today announced an extension of its successful collaboration with Versartis, Inc. following the recent initiation of a Phase 1 clinical trial in type 2 diabetes mellitus (T2DM) patients with monthly dosing of VRS-859. This news comes less than 12 months since the parties entered into a strategic partnership to manufacture Versartis' lead product VRS-859 (exenatide-XTEN).
The notion that more medical errors occur in July compared to other months due to an influx of new medical school graduates starting their in-hospital training does not apply to heart surgery, according to research in The Annals of Thoracic Surgery, published by Elsevier.
Kolltan Pharmaceuticals, Inc. announced today that it has raised an additional $5 million to close its Series A preferred stock financing at $40 million. Participants in the Series A financing, originally announced in January 2009, include Purdue Pharma, L.P., HBM BioCapital L.P., the Pritzker/Vlock family, and other substantial private life science investors.
› Verified 6 days ago
Dr. Christopher Dean Prevel, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 5979 Vineland Rd, Suite 114, Orlando, FL 32819 Phone: 407-352-1818 Fax: 407-352-1814 | |
Dr. Kenrick Anthony Spence I, M.D., F.A.C.S. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 130 Hillcrest St, Orlando, FL 32801 Phone: 407-999-2585 Fax: 407-999-2628 | |
Dr. Luis Alejandro Jaramillo, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14050 Town Loop Blvd, Suite 204, Orlando, FL 32837 Phone: 407-251-8800 | |
Dr. Angelo Alberto Leto Barone, Plastic Surgery Medicare: Medicare Enrolled Practice Location: 6535 Nemours Pkwy, Orlando, FL 32827 Phone: 407-567-4000 Fax: 407-567-5924 | |
Dr. Jerry Alan Rubin, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6900 Turkey Lake Rd, Suite 1-7, Orlando, FL 32819 Phone: 321-939-3300 Fax: 321-939-3303 | |
Dr. Omar E Beidas, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 265 E Rollins St Ste 5300, Orlando, FL 32804 Phone: 407-821-3555 Fax: 407-821-3556 |